海辰药业
(300584)
| 流通市值：23.14亿 | | | 总市值：33.80亿 |
| 流通股本：8213.15万 | | | 总股本：1.20亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 364,148,083.65 | 160,335,652.32 | 671,048,953.77 | 471,526,892.93 |
| 营业总成本 | 311,627,648.84 | 142,276,527.05 | 589,280,857.55 | 424,895,894.17 |
| 其他经营收益 | | | | |
| 营业利润 | 42,869,659.94 | 15,205,913.96 | 46,388,435.52 | 31,874,934.21 |
| 利润总额 | 37,999,913.73 | 14,984,459.16 | 47,300,075.19 | 34,849,973.84 |
| 净利润 | 32,892,970.11 | 16,334,121.84 | 40,732,040.52 | 32,194,633.14 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 32,892,970.11 | 16,334,121.84 | 40,732,040.52 | 32,194,633.14 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 383,851,054.55 | 383,741,560.77 | 384,322,015.67 | 352,440,756.23 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,132,557,335.36 | 1,148,055,462.87 | 1,147,769,015.81 | 1,130,934,881.32 |
| 资产总计 | 1,516,408,389.91 | 1,531,797,023.64 | 1,532,091,031.48 | 1,483,375,637.55 |
| 流动负债: | | | | |
| 流动负债合计 | 323,758,090.44 | 359,795,617.89 | 368,937,021.21 | 349,509,477.12 |
| 非流动负债: | | | | |
| 非流动负债合计 | 71,811,982.33 | 55,868,105.15 | 63,318,851.76 | 60,628,337.31 |
| 负债合计 | 395,570,072.77 | 415,663,723.04 | 432,255,872.97 | 410,137,814.43 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,073,445,609.94 | 1,070,597,429.82 | 1,053,270,437.87 | 1,043,329,086.59 |
| 股东权益合计 | 1,120,838,317.14 | 1,116,133,300.6 | 1,099,835,158.51 | 1,073,237,823.12 |
| 负债和股东权益合计 | 1,516,408,389.91 | 1,531,797,023.64 | 1,532,091,031.48 | 1,483,375,637.55 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 319,046,005.19 | 168,185,776.01 | 664,047,870.87 | 477,727,059.54 |
| 经营活动现金流出小计 | 319,924,070.96 | 157,571,254.95 | 585,958,738 | 419,240,390.75 |
| 经营活动产生的现金流量净额 | -878,065.77 | 10,614,521.06 | 78,089,132.87 | 58,486,668.79 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 37,169.39 | 37,134.88 | 30,500,344.95 | 60,076,879.06 |
| 投资活动现金流出小计 | 17,253,988.77 | 13,113,744.11 | 71,739,934.11 | 66,209,231.52 |
| 投资活动产生的现金流量净额 | -17,216,819.38 | -13,076,609.23 | -41,239,589.16 | -6,132,352.46 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 114,919,111.11 | 57,919,111.11 | 286,400,000 | 203,100,000 |
| 筹资活动现金流出小计 | 140,118,289.47 | 50,407,449.87 | 302,834,526.02 | 225,088,756.49 |
| 筹资活动产生的现金流量净额 | -25,199,178.36 | 7,511,661.24 | -16,434,526.02 | -21,988,756.49 |
| 汇率变动对现金及现金等价物的影响 | -12,540.04 | -8,046.23 | 17,092.59 | 19,877.48 |
| 现金及现金等价物净增加额 | -43,306,603.55 | 5,041,526.84 | 20,432,110.28 | 30,385,437.32 |
| 期末现金及现金等价物余额 | 22,884,224.56 | 71,232,354.95 | 66,190,828.11 | 76,144,155.15 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -43,306,603.55 | - | 20,432,110.28 | - |